Factors in the TME have been implicated in the regulation of Fz7 on colorectal cancer cells[13] and Fz7 downregulation has been linked to reduced survival, invasion and metastatic potential[14], suggesting that Fz7 may represent a therapeutic target. The gene discussed is FZD7; the disease is colorectal cancer.